OpenURL Connection Search

Select item for more details and to access through your institution.

Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
Published in:
Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102143
By:
- Skelton IV, William Paul;
- Masur, Jack;
- Thomas, Jonathan;
- Fallah, Parvaneh;
- Jain, Rohit K.;
- Ravi, Praful;
- Mantia, Charlene;
- McGregor, Bradley Alexander;
- Nuzzo, Pier Vitale;
- Adib, Elio;
- Zarif, Talal El;
- Preston, Mark A.;
- Clinton, Timothy Nguyen;
- Li, Roger;
- Steele, Graeme S.;
- Kassouf, Wassim;
- Freeman, Dory;
- Pond, Gregory Russell;
- Jain, Rakesh K.;
- Sonpavde, Guru P.
Publication type:
Article
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 775, doi. 10.1007/s00262-022-03274-6
By:
- Sonpavde, Guru P.;
- Maughan, Benjamin Louis;
- McGregor, Bradley Alexander;
- Wei, Xiao X.;
- Kilbridge, Kerry L.;
- Lee, Richard J.;
- Yu, Evan Y.;
- Schweizer, Michael Thomas;
- Montgomery, Robert B.;
- Cheng, Heather H.;
- Hsieh, Andrew Caleb;
- Jain, Rohit;
- Grewal, Jaspreet S.;
- Pico-Navarro, Cesar;
- Gafoor, Zarina;
- Perschy, Teresa;
- Grivas, Petros
Publication type:
Article
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Published in:
Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328
By:
- McGregor, Bradley Alexander;
- Campbell, Matthew T.;
- Xie, Wanling;
- Farah, Subrina;
- Bilen, Mehmet A.;
- Schmidt, Andrew L.;
- Sonpavde, Guru P.;
- Kilbridge, Kerry L.;
- Choudhury, Atish D.;
- Mortazavi, Amir;
- Shah, Amishi Y.;
- Venkatesan, Aradhana M.;
- Bubley, Glenn J.;
- Siefker‐Radtke, Arlene O.;
- McKay, Rana R.;
- Choueiri, Toni K.
Publication type:
Article

Found: 3

Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.

Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.